[
  {
    "ts": null,
    "headline": "Moderna Slammed By 'Fear, Confusion' After FDA Alleges Covid Shots Killed 10",
    "summary": "Moderna and other vaccine stocks tumbled Monday after an FDA director reportedly issued a memo that says Covid shots killed 10 children.",
    "url": "https://finnhub.io/api/news?id=61b201b89baeb9d13aedbc60959b4c3899d7e8b0979336aaae4ea16cb2da18e6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764625289,
      "headline": "Moderna Slammed By 'Fear, Confusion' After FDA Alleges Covid Shots Killed 10",
      "id": 137659244,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Moderna and other vaccine stocks tumbled Monday after an FDA director reportedly issued a memo that says Covid shots killed 10 children.",
      "url": "https://finnhub.io/api/news?id=61b201b89baeb9d13aedbc60959b4c3899d7e8b0979336aaae4ea16cb2da18e6"
    }
  },
  {
    "ts": null,
    "headline": "FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks",
    "summary": "Shares of several major vaccine makers lost ground Monday following a report U.S. vaccine approval rules could become stricter.",
    "url": "https://finnhub.io/api/news?id=4891d34863b8b93ba5ab2a772cfe5faf5e7a4197ee1159534590eae6b939f025",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764619557,
      "headline": "FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks",
      "id": 137659245,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Shares of several major vaccine makers lost ground Monday following a report U.S. vaccine approval rules could become stricter.",
      "url": "https://finnhub.io/api/news?id=4891d34863b8b93ba5ab2a772cfe5faf5e7a4197ee1159534590eae6b939f025"
    }
  },
  {
    "ts": null,
    "headline": "U.S., U.K. Strike Deal on Higher Drug Prices",
    "summary": "The move marks a victory for the Trump administration’s campaign to get other countries to pay more for drugs.",
    "url": "https://finnhub.io/api/news?id=4bc02f2343ae67bb9b8f526f5a9d3f3169ed6ce73bf0ac56cf488bd54df180d9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764613980,
      "headline": "U.S., U.K. Strike Deal on Higher Drug Prices",
      "id": 137658835,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The move marks a victory for the Trump administration’s campaign to get other countries to pay more for drugs.",
      "url": "https://finnhub.io/api/news?id=4bc02f2343ae67bb9b8f526f5a9d3f3169ed6ce73bf0ac56cf488bd54df180d9"
    }
  },
  {
    "ts": null,
    "headline": "Vaccine makers fall on FDA memo, Bally's wins bid for NYC casino",
    "summary": "Market Catalysts host Julie Hyman tracks several of the day's top trending stock tickers, including the stock hit vaccine makers Moderna (MRNA), BioNTech (BNTX), and Novavax (NVAX) are taking on following a memo from the US Food and Drug Administration (FDA); casino operator Bally's (BALY) has won approval to run casinos in New York City; and Somnigroup International's (SGI) $1.6 billion offer to acquire Leggett & Platt (LEG). To watch more expert insights and analysis on the latest market action, check out more Market Catalysts.",
    "url": "https://finnhub.io/api/news?id=79741ea3b2b9159e0439710a4a44471ec8ae656289dc9f313d1bca72e660d9f4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764608953,
      "headline": "Vaccine makers fall on FDA memo, Bally's wins bid for NYC casino",
      "id": 137659247,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Market Catalysts host Julie Hyman tracks several of the day's top trending stock tickers, including the stock hit vaccine makers Moderna (MRNA), BioNTech (BNTX), and Novavax (NVAX) are taking on following a memo from the US Food and Drug Administration (FDA); casino operator Bally's (BALY) has won approval to run casinos in New York City; and Somnigroup International's (SGI) $1.6 billion offer to acquire Leggett & Platt (LEG). To watch more expert insights and analysis on the latest market action, check out more Market Catalysts.",
      "url": "https://finnhub.io/api/news?id=79741ea3b2b9159e0439710a4a44471ec8ae656289dc9f313d1bca72e660d9f4"
    }
  },
  {
    "ts": null,
    "headline": "Moderna and Novavax Stocks Drop as FDA Outlines Stricter Vaccine Approvals",
    "summary": "The FDA’s top vaccine regulator outlines proposed changes to the vaccine evaluation process in an internal memo.",
    "url": "https://finnhub.io/api/news?id=5bc508ad62df578c992ff8018680be47c25ff31ee799040e0f3aa5c38eec67d4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764605100,
      "headline": "Moderna and Novavax Stocks Drop as FDA Outlines Stricter Vaccine Approvals",
      "id": 137659248,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The FDA’s top vaccine regulator outlines proposed changes to the vaccine evaluation process in an internal memo.",
      "url": "https://finnhub.io/api/news?id=5bc508ad62df578c992ff8018680be47c25ff31ee799040e0f3aa5c38eec67d4"
    }
  },
  {
    "ts": null,
    "headline": "Will Korlym Continue to Drive Corcept's Top Line in 2026?",
    "summary": "CORT leans on rising Korlym sales while awaiting key relacorilant FDA decisions that could broaden its growth path in 2026.",
    "url": "https://finnhub.io/api/news?id=4cd1708e495ab0c8aaeb3d5447948b4f95e80bd83edd02d8eafd0d194fab4f50",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764605040,
      "headline": "Will Korlym Continue to Drive Corcept's Top Line in 2026?",
      "id": 137659249,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "CORT leans on rising Korlym sales while awaiting key relacorilant FDA decisions that could broaden its growth path in 2026.",
      "url": "https://finnhub.io/api/news?id=4cd1708e495ab0c8aaeb3d5447948b4f95e80bd83edd02d8eafd0d194fab4f50"
    }
  },
  {
    "ts": null,
    "headline": "AMGN Up Almost 16% in a Month: Should You Buy, Sell or Hold the Stock?",
    "summary": "Amgen's nearly 16% surge follows strong Q3 results, raised sales guidance and growing momentum across key drugs and biosimilars.",
    "url": "https://finnhub.io/api/news?id=78d2fbdffc373e7d6e89b8f8320cc8da650da2e6559f9b9f047819ae4b04b2ca",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764604800,
      "headline": "AMGN Up Almost 16% in a Month: Should You Buy, Sell or Hold the Stock?",
      "id": 137658837,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Amgen's nearly 16% surge follows strong Q3 results, raised sales guidance and growing momentum across key drugs and biosimilars.",
      "url": "https://finnhub.io/api/news?id=78d2fbdffc373e7d6e89b8f8320cc8da650da2e6559f9b9f047819ae4b04b2ca"
    }
  },
  {
    "ts": null,
    "headline": "Moderna, Novavax Shares Fall on News FDA Plans to Tighten Vaccine Approvals",
    "summary": "Shares of two major Covid-19 vaccine makers declined Monday after a Food and Drug Administration official claimed the shots led to 10 children’s deaths and said the agency would tighten vaccine-approval standards.  Shares of Moderna and Novavax, which depend heavily on Covid-19 vaccine sales for revenue, fell about 6% and 3.5%, respectively.  Stock in Pfizer, whose Covid-19 vaccine sales are a smaller percentage of total company revenue, ticked higher.",
    "url": "https://finnhub.io/api/news?id=ab121e2470971a825c8c92a6f49f66115dbf7537fbce8397f46920132b078e10",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764602857,
      "headline": "Moderna, Novavax Shares Fall on News FDA Plans to Tighten Vaccine Approvals",
      "id": 137659251,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Shares of two major Covid-19 vaccine makers declined Monday after a Food and Drug Administration official claimed the shots led to 10 children’s deaths and said the agency would tighten vaccine-approval standards.  Shares of Moderna and Novavax, which depend heavily on Covid-19 vaccine sales for revenue, fell about 6% and 3.5%, respectively.  Stock in Pfizer, whose Covid-19 vaccine sales are a smaller percentage of total company revenue, ticked higher.",
      "url": "https://finnhub.io/api/news?id=ab121e2470971a825c8c92a6f49f66115dbf7537fbce8397f46920132b078e10"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Invites Public to View and Listen to Webcast of December 16 Conference Call with Analysts to Provide Full-Year 2026 Financial Guidance",
    "summary": "NEW YORK, December 01, 2025--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 8:00 a.m. EST on Tuesday, December 16, 2025. The purpose of the call is to provide Pfizer’s full-year 2026 financial guidance.",
    "url": "https://finnhub.io/api/news?id=ac10d04e8063e29a78d4c8f004b81a3b79ae7dd6c9b570218de89527be467180",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764601200,
      "headline": "Pfizer Invites Public to View and Listen to Webcast of December 16 Conference Call with Analysts to Provide Full-Year 2026 Financial Guidance",
      "id": 137659252,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "NEW YORK, December 01, 2025--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 8:00 a.m. EST on Tuesday, December 16, 2025. The purpose of the call is to provide Pfizer’s full-year 2026 financial guidance.",
      "url": "https://finnhub.io/api/news?id=ac10d04e8063e29a78d4c8f004b81a3b79ae7dd6c9b570218de89527be467180"
    }
  },
  {
    "ts": null,
    "headline": "VKTX Stock Rises 34% in Three Months: Here's What You Should Know",
    "summary": "Viking Therapeutics' shares jump 34% as rapid VK2735 trial enrollment boosts optimism amid intensifying interest in obesity treatments.",
    "url": "https://finnhub.io/api/news?id=1d5a6130ab74aedcf6be0416607e5824cfb54393a2b573332ca3d0a8b023dd95",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764599160,
      "headline": "VKTX Stock Rises 34% in Three Months: Here's What You Should Know",
      "id": 137658840,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Viking Therapeutics' shares jump 34% as rapid VK2735 trial enrollment boosts optimism amid intensifying interest in obesity treatments.",
      "url": "https://finnhub.io/api/news?id=1d5a6130ab74aedcf6be0416607e5824cfb54393a2b573332ca3d0a8b023dd95"
    }
  },
  {
    "ts": null,
    "headline": "Cadrenal Therapeutics Appoints Dr. Lee Golden to Board of Directors",
    "summary": "PONTE VEDRA, Fla., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome current gaps in anticoagulation therapy, today announced the appointment of Lee Scott Golden, M.D., to its Board of Directors, effective immediately. Dr. Golden will serve as an independent director. Dr. Golden currently serves as Executive Vice President and Chief Medical Officer at PTC Therapeutics, Inc. (Nasdaq: PTCT),",
    "url": "https://finnhub.io/api/news?id=cecceb4984c37d5b705aee39fafd6f40a5ed9494553aec1066b902ead6f9ced2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764597600,
      "headline": "Cadrenal Therapeutics Appoints Dr. Lee Golden to Board of Directors",
      "id": 137659254,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "PONTE VEDRA, Fla., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome current gaps in anticoagulation therapy, today announced the appointment of Lee Scott Golden, M.D., to its Board of Directors, effective immediately. Dr. Golden will serve as an independent director. Dr. Golden currently serves as Executive Vice President and Chief Medical Officer at PTC Therapeutics, Inc. (Nasdaq: PTCT),",
      "url": "https://finnhub.io/api/news?id=cecceb4984c37d5b705aee39fafd6f40a5ed9494553aec1066b902ead6f9ced2"
    }
  },
  {
    "ts": null,
    "headline": "Shares of vaccine makers drop after FDA memo flags reports of child deaths",
    "summary": "Investing.com -- Shares in major COVID-19 vaccine makers fell on Monday after an internal U.S. Food and Drug Administration (FDA) memo reportedly suggested that vaccinations may have contributed to several child deaths linked to heart inflammation.",
    "url": "https://finnhub.io/api/news?id=778a14cd19d2eb1bdb871c995fff0affeeec857214bc12b62b16e20a96233839",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764592476,
      "headline": "Shares of vaccine makers drop after FDA memo flags reports of child deaths",
      "id": 137659255,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Investing.com -- Shares in major COVID-19 vaccine makers fell on Monday after an internal U.S. Food and Drug Administration (FDA) memo reportedly suggested that vaccinations may have contributed to several child deaths linked to heart inflammation.",
      "url": "https://finnhub.io/api/news?id=778a14cd19d2eb1bdb871c995fff0affeeec857214bc12b62b16e20a96233839"
    }
  },
  {
    "ts": null,
    "headline": "1 Profitable Stock on Our Buy List and 2 We Turn Down",
    "summary": "While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, \"Your margin is my opportunity\".",
    "url": "https://finnhub.io/api/news?id=cdf1878975bdfb369425a3a7085d032c6b384324e07d09f73f525bff38ac4a01",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764587492,
      "headline": "1 Profitable Stock on Our Buy List and 2 We Turn Down",
      "id": 137659256,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, \"Your margin is my opportunity\".",
      "url": "https://finnhub.io/api/news?id=cdf1878975bdfb369425a3a7085d032c6b384324e07d09f73f525bff38ac4a01"
    }
  },
  {
    "ts": null,
    "headline": "Stock market holiday shopping: How to find quality value names",
    "summary": "Retailers aren't the only ones with holiday sales; investors can also find high value for low prices in the stock market (^DJI, ^GSPC, ^IXIC). Yahoo Finance Markets and Data Editor Jared Blikre, who also hosts Yahoo Finance's Stocks in Translation podcast, explains where investors should look to find the best value stocks this holiday season. Catch more Stocks in Translation, with new episodes every Tuesday and Thursday. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts.",
    "url": "https://finnhub.io/api/news?id=08313ce6aa2a42f52004d40ebfaf6931f94f276adfc85dd25f4e5935065150bd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764586825,
      "headline": "Stock market holiday shopping: How to find quality value names",
      "id": 137659257,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Retailers aren't the only ones with holiday sales; investors can also find high value for low prices in the stock market (^DJI, ^GSPC, ^IXIC). Yahoo Finance Markets and Data Editor Jared Blikre, who also hosts Yahoo Finance's Stocks in Translation podcast, explains where investors should look to find the best value stocks this holiday season. Catch more Stocks in Translation, with new episodes every Tuesday and Thursday. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts.",
      "url": "https://finnhub.io/api/news?id=08313ce6aa2a42f52004d40ebfaf6931f94f276adfc85dd25f4e5935065150bd"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie: Increased Outlook For 2025 And Expansions Merit Continued \"Strong Buy\" Rating",
    "summary": "Discover why AbbVie (ABBV) is a strong buy with expanding immunology, neuroscience, and oncology pipelines.",
    "url": "https://finnhub.io/api/news?id=cd344b45351b5568fb3d4c58324967399568fd6ee1adbe6e67322c5ec346dc6d",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764568505,
      "headline": "AbbVie: Increased Outlook For 2025 And Expansions Merit Continued \"Strong Buy\" Rating",
      "id": 137651736,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2247731311/image_2247731311.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Discover why AbbVie (ABBV) is a strong buy with expanding immunology, neuroscience, and oncology pipelines.",
      "url": "https://finnhub.io/api/news?id=cd344b45351b5568fb3d4c58324967399568fd6ee1adbe6e67322c5ec346dc6d"
    }
  },
  {
    "ts": null,
    "headline": "2 Undervalued, High-Quality Companies to Buy Now and Hold Forever",
    "summary": "If you are looking to own a stock for the long term, these out-of-favor drugmakers have proven they have what it takes to survive.",
    "url": "https://finnhub.io/api/news?id=15560fee524920002e1518664dcc0ea6c8ab46fe1c923913fd80fd84f81ec4a3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764554700,
      "headline": "2 Undervalued, High-Quality Companies to Buy Now and Hold Forever",
      "id": 137650213,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "If you are looking to own a stock for the long term, these out-of-favor drugmakers have proven they have what it takes to survive.",
      "url": "https://finnhub.io/api/news?id=15560fee524920002e1518664dcc0ea6c8ab46fe1c923913fd80fd84f81ec4a3"
    }
  }
]